As of 2025-05-23, the Intrinsic Value of Rossari Biotech Ltd (ROSSARI.NS) is 515.02 INR. This ROSSARI.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 656.15 INR, the upside of Rossari Biotech Ltd is -21.40%.
The range of the Intrinsic Value is 426.22 - 651.96 INR
Based on its market price of 656.15 INR and our intrinsic valuation, Rossari Biotech Ltd (ROSSARI.NS) is overvalued by 21.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 426.22 - 651.96 | 515.02 | -21.4% |
| DCF (Growth 10y) | 640.31 - 979.95 | 774.91 | 18.3% |
| DCF (EBITDA 5y) | 1,253.63 - 1,735.41 | 1,425.79 | 117.7% |
| DCF (EBITDA 10y) | 1,324.21 - 2,012.84 | 1,582.91 | 141.7% |
| Fair Value | 397.59 - 397.59 | 397.59 | -39.41% |
| P/E | 745.81 - 1,278.51 | 998.92 | 52.5% |
| EV/EBITDA | 666.52 - 945.31 | 782.73 | 19.5% |
| EPV | 188.52 - 240.87 | 214.70 | -67.2% |
| DDM - Stable | 107.03 - 212.76 | 159.89 | -75.6% |
| DDM - Multi | 347.04 - 557.64 | 429.62 | -34.4% |
| Market Cap (mil) | 36,331.03 |
| Beta | 0.74 |
| Outstanding shares (mil) | 55.37 |
| Enterprise Value (mil) | 37,744.25 |
| Market risk premium | 8.31% |
| Cost of Equity | 16.76% |
| Cost of Debt | 7.56% |
| WACC | 16.44% |